tiprankstipranks
Trending News
More News >
Neurocrine (NBIX)
NASDAQ:NBIX
US Market
Advertisement

Neurocrine (NBIX) Ratios

Compare
1,504 Followers

Neurocrine Ratios

NBIX's free cash flow for Q3 2025 was $0.98. For the 2025 fiscal year, NBIX's free cash flow was decreased by $ and operating cash flow was $0.37. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.38 2.45 2.70 3.96 5.45
Quick Ratio
3.27 2.40 2.64 3.83 5.30
Cash Ratio
0.53 0.38 0.49 1.39 4.29
Solvency Ratio
0.36 0.27 0.26 0.14 0.68
Operating Cash Flow Ratio
1.00 0.60 0.63 1.04 1.23
Short-Term Operating Cash Flow Coverage
0.00 2.29 2.00 0.00 0.00
Net Current Asset Value
$ 896.30M$ 587.60M$ 792.60M$ 274.30M$ 407.70M
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.13 0.11 0.21 0.24
Debt-to-Equity Ratio
0.14 0.19 0.15 0.32 0.37
Debt-to-Capital Ratio
0.12 0.16 0.13 0.24 0.27
Long-Term Debt-to-Capital Ratio
0.12 0.00 0.00 0.20 0.22
Financial Leverage Ratio
1.42 1.46 1.39 1.51 1.54
Debt Service Coverage Ratio
0.00 1.58 1.16 8.02 19.41
Interest Coverage Ratio
0.00 54.54 35.07 7.63 9.72
Debt to Market Cap
0.03 0.01 0.01 0.04 0.04
Interest Debt Per Share
4.31 4.43 2.82 4.93 4.78
Net Debt to EBITDA
0.13 0.50 0.00 0.46 -1.16
Profitability Margins
Gross Profit Margin
98.37%97.90%98.44%98.74%99.03%
EBIT Margin
23.70%17.84%16.73%18.33%31.31%
EBITDA Margin
24.80%18.97%17.77%19.29%32.14%
Operating Profit Margin
20.51%13.30%16.73%17.37%30.49%
Pretax Profit Margin
23.43%17.60%14.37%8.95%10.20%
Net Profit Margin
15.95%13.23%10.38%7.90%38.94%
Continuous Operations Profit Margin
15.95%13.23%10.38%7.90%38.94%
Net Income Per EBT
68.09%75.19%72.23%88.36%381.72%
EBT Per EBIT
114.25%132.36%85.90%51.50%33.46%
Return on Assets (ROA)
10.03%7.68%6.52%4.32%23.48%
Return on Equity (ROE)
15.82%11.19%9.05%6.52%36.17%
Return on Capital Employed (ROCE)
15.17%9.66%13.60%10.78%20.60%
Return on Invested Capital (ROIC)
10.33%6.82%8.99%9.52%78.63%
Return on Tangible Assets
10.12%7.76%6.63%4.32%23.48%
Earnings Yield
3.01%1.94%1.35%1.11%4.56%
Efficiency Ratios
Receivables Turnover
3.69 4.30 4.25 6.11 6.66
Payables Turnover
0.37 0.36 0.34 0.28 0.26
Inventory Turnover
0.63 1.04 0.66 0.47 0.36
Fixed Asset Turnover
4.74 5.43 10.22 7.28 8.21
Asset Turnover
0.63 0.58 0.63 0.55 0.60
Working Capital Turnover Ratio
1.97 2.02 1.81 1.46 1.91
Cash Conversion Cycle
-322.62 -564.12 -420.78 -476.28 -357.16
Days of Sales Outstanding
99.05 84.97 85.81 59.73 54.83
Days of Inventory Outstanding
577.50 352.13 552.22 778.50 1.01K
Days of Payables Outstanding
999.17 1.00K 1.06K 1.31K 1.42K
Operating Cycle
676.55 437.10 638.03 838.23 1.07K
Cash Flow Ratios
Operating Cash Flow Per Share
6.41 3.99 3.54 2.71 2.45
Free Cash Flow Per Share
5.97 3.70 3.37 2.46 2.34
CapEx Per Share
0.44 0.29 0.17 0.25 0.12
Free Cash Flow to Operating Cash Flow
0.93 0.93 0.95 0.91 0.95
Dividend Paid and CapEx Coverage Ratio
14.57 13.78 20.57 10.96 20.96
Capital Expenditure Coverage Ratio
14.57 13.78 20.57 10.96 20.96
Operating Cash Flow Coverage Ratio
1.49 0.91 1.29 0.58 0.55
Operating Cash Flow to Sales Ratio
0.24 0.21 0.23 0.23 0.22
Free Cash Flow Yield
4.16%2.81%2.82%2.89%2.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
33.26 51.55 74.06 89.92 21.91
Price-to-Sales (P/S) Ratio
5.31 6.82 7.69 7.11 8.53
Price-to-Book (P/B) Ratio
4.74 5.77 6.70 5.86 7.92
Price-to-Free Cash Flow (P/FCF) Ratio
24.01 35.60 35.44 34.56 41.01
Price-to-Operating Cash Flow Ratio
22.35 33.02 33.71 31.41 39.05
Price-to-Earnings Growth (PEG) Ratio
1.39 0.87 1.07 -1.15 0.02
Price-to-Fair Value
4.74 5.77 6.70 5.86 7.92
Enterprise Value Multiple
21.54 36.45 43.24 37.30 25.39
Enterprise Value
14.33B 13.05B 11.44B 8.16B 8.53B
EV to EBITDA
21.54 36.45 43.24 37.30 25.39
EV to Sales
5.34 6.92 7.69 7.20 8.16
EV to Free Cash Flow
24.16 36.09 35.44 34.99 39.22
EV to Operating Cash Flow
22.50 33.47 33.71 31.80 37.35
Tangible Book Value Per Share
29.86 22.48 17.38 14.52 12.10
Shareholders’ Equity Per Share
30.22 22.85 17.83 14.52 12.10
Tax and Other Ratios
Effective Tax Rate
0.32 0.25 0.28 0.12 -2.82
Revenue Per Share
26.99 19.32 15.54 11.98 11.23
Net Income Per Share
4.31 2.56 1.61 0.95 4.37
Tax Burden
0.68 0.75 0.72 0.88 3.82
Interest Burden
0.99 0.99 0.86 0.49 0.33
Research & Development to Revenue
0.35 0.30 0.31 0.29 0.26
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.08 0.10 0.12 0.12 0.10
Income Quality
1.49 1.56 2.20 2.86 0.56
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis